| Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature D Garg, V Muthu, IS Sehgal, R Ramachandran, H Kaur, A Bhalla, GD Puri, ... Mycopathologia 186 (2), 289-298, 2021 | 644 | 2021 |
| Multicenter epidemiologic study of Coronavirus disease–associated mucormycosis, India A Patel, R Agarwal, SM Rudramurthy, M Shevkani, I Xess, R Sharma, ... Emerging infectious diseases 27 (9), 2349, 2021 | 465 | 2021 |
| A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India A Patel, H Kaur, I Xess, JS Michael, J Savio, S Rudramurthy, R Singh, ... Clinical Microbiology and Infection 26 (7), 944. e9-944. e15, 2020 | 422 | 2020 |
| Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world V Muthu, SM Rudramurthy, A Chakrabarti, R Agarwal Mycopathologia 186 (6), 739-754, 2021 | 223 | 2021 |
| ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries SM Rudramurthy, M Hoenigl, JF Meis, OA Cornely, V Muthu, ... Mycoses 64 (9), 1028-1037, 2021 | 197 | 2021 |
| Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations R Agarwal, S Dhooria, AN Aggarwal, VN Maturu, IS Sehgal, V Muthu, ... Lung India: official organ of Indian Chest Society 32 (Suppl 1), S3, 2015 | 122 | 2015 |
| Allergic bronchopulmonary aspergillosis R Agarwal, IS Sehgal, S Dhooria, V Muthu, KT Prasad, A Bal, ... The Indian Journal of Medical Research 151 (6), 529, 2020 | 109 | 2020 |
| Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis V Muthu, R Agarwal, S Dhooria, IS Sehgal, KT Prasad, AN Aggarwal, ... Clinical Microbiology and Infection 27 (4), 538-549, 2021 | 94 | 2021 |
| Allergic Bronchopulmonary Aspergillosis R Agarwal, V Muthu, IS Sehgal, S Dhooria, KT Prasad, AN Aggarwal Clinics in Chest Medicine 43 (1), 99-125, 2022 | 72 | 2022 |
| Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis P Saxena, H Choudhary, V Muthu, IS Sehgal, S Dhooria, KT Prasad, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (1), 328-335. e1, 2021 | 67 | 2021 |
| Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis AN Aggarwal, R Agarwal, S Dhooria, KT Prasad, IS Sehgal, V Muthu PloS one 16 (10), e0259006, 2021 | 63 | 2021 |
| High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial) S Dhooria, S Chaudhary, IS Sehgal, R Agarwal, S Arora, M Garg, ... European Respiratory Journal 59 (2), 2022 | 62 | 2022 |
| Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary … V Muthu, R Agarwal, A Patel, S Kathirvel, OC Abraham, AN Aggarwal, ... The Lancet Infectious Diseases 22 (9), e240-e253, 2022 | 59 | 2022 |
| Transforming a general hospital to an infectious disease hospital for COVID-19 over 2 weeks N Pandey, V Kaushal, GD Puri, S Taneja, M Biswal, P Mahajan, RR Guru, ... Frontiers in public health 8, 382, 2020 | 59 | 2020 |
| Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: A systematic review and diagnostic test accuracy … V Muthu, IS Sehgal, S Dhooria, AN Aggarwal, R Agarwal Clinical & Experimental Allergy 48 (9), 1107-1136, 2018 | 58 | 2018 |
| A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma R Agarwal, V Muthu, IS Sehgal, S Dhooria, KT Prasad, M Garg, ... European Respiratory Journal 59 (4), 2022 | 51 | 2022 |
| Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis V Muthu, P Singh, H Choudhary, IS Sehgal, S Dhooria, KT Prasad, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (2), 579-587, 2020 | 51 | 2020 |
| Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India. V Muthu, R Agarwal, SM Rudramurthy, D Thangaraju, MR Shevkani, ... Emerging Infectious Diseases 29 (1), 2023 | 45 | 2023 |
| Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in … IS Sehgal, S Dhooria, V Muthu, KT Prasad, AN Aggarwal, A Chakrabarti, ... The Lancet Infectious Diseases 22 (7), 1052-1061, 2022 | 45 | 2022 |
| CT Findings of COVID-19–associated pulmonary mucormycosis: a case series and literature review M Garg, N Prabhakar, V Muthu, S Farookh, H Kaur, V Suri, R Agarwal Radiology 302 (1), 214-217, 2022 | 44 | 2022 |
Ritesh AgarwalDepartment of Pulmonary Medicine, PGIMER, Chandigarh在 pgimer.edu.in 的電子郵件地址已通過驗證